There are 2789 resources available
1868P - Real-world safety of the 6-weekly pembrolizumab regimen in cancer patients treated in South East London
Presenter: Matthaios Kapiris
Session: ePoster Display
1869TiP - A phase II, multicenter, open-label study evaluating trastuzumab deruxtecan (T-DXd) for the treatment of select HER2-expressing solid tumors (DESTINY-PanTumor02)
Presenter: Funda Meric-Bernstam
Session: ePoster Display
1870TiP - Tazemetostat in combination with a PARP Inhibitor or checkpoint inhibitor in patients (Pts) with solid tumors
Presenter: Charles Rudin
Session: ePoster Display
Introduction
Presenter: Victor Moreno Garcia
Session: Testing for fusions: When and how?
Resources:
Slides
Established and promising new gene fusions inhibitors and new drugs
Presenter: Victor Moreno Garcia
Session: Testing for fusions: When and how?
Resources:
Slides
Webcast
The relative merits of different approaches to fusion testing
Presenter: Ana Vivancos
Session: Testing for fusions: When and how?
Resources:
Slides
Webcast
Confusion on fusion testing
Presenter: Alexander Drilon
Session: Testing for fusions: When and how?
Resources:
Slides
Webcast
Introduction
Presenter: Eliezer Van Allen
Session: Convergence of advanced computation and big data to accelerate precision cancer medicine
Resources:
Webcast
Genomics and machine learning for precision cancer medicine
Presenter: Eliezer Van Allen
Session: Convergence of advanced computation and big data to accelerate precision cancer medicine
Resources:
Webcast
AI for image analysis of cancer therapy response
Presenter: Evis Sala
Session: Convergence of advanced computation and big data to accelerate precision cancer medicine
Resources:
Slides